GLP-1 Agonist: What It Is, How It Works & Who It's For

What is a GLP-1 agonist?

If you've been researching medical weight loss, you've likely come across the term GLP-1 agonist — a class of medications that's reshaping how clinicians approach obesity and metabolic health. Originally developed for type 2 diabetes, GLP-1 agonists are now FDA-approved for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition.

But what does "GLP-1 agonist" actually mean? And more importantly, how does it work in your body?

GLP-1 stands for glucagon-like peptide-1, a hormone your gut naturally produces after you eat. It signals fullness, slows digestion, and helps regulate blood sugar. A GLP-1 agonist is a medication that mimics this hormone — binding to the same receptors and amplifying the effect. The result: reduced appetite, improved satiety, and, for many people, significant weight loss.

This isn't about willpower or restrictive dieting. It's about working with your biology.

How GLP-1 agonists work in your body

When you eat, your intestines release GLP-1 as part of the incretin system — a network of hormones that regulate metabolism. Natural GLP-1 has a short half-life, breaking down within minutes. GLP-1 agonist medications are engineered to last much longer, giving your body sustained hormonal support throughout the day or week.

Here's what happens when you take a GLP-1 agonist:

Appetite suppression

GLP-1 receptors in the brain's hypothalamus receive signals that you're full. This isn't a stimulant effect — it's a recalibration of hunger cues. Many patients report feeling satisfied with smaller portions without the usual sense of deprivation.

Slowed gastric emptying

The medication slows the rate at which food leaves your stomach. This prolongs the sensation of fullness and reduces post-meal blood sugar spikes. It's why some people experience early satiety or mild nausea, especially in the first few weeks.

Improved insulin response

GLP-1 agonists stimulate insulin secretion only when blood sugar is elevated, which helps prevent hypoglycemia. This is particularly beneficial for people with prediabetes or metabolic syndrome.

Reduced glucagon secretion

Glucagon is a hormone that raises blood sugar. GLP-1 agonists suppress its release, contributing to better glycemic control and less fat storage.

Together, these mechanisms create an environment where weight loss becomes more achievable — not through restriction, but through metabolic recalibration.

FDA-approved GLP-1 agonists for weight loss

Several GLP-1 agonist medications are FDA-approved for chronic weight management. The two most widely prescribed are semaglutide and tirzepatide.

Semaglutide

Semaglutide is a pure GLP-1 receptor agonist, approved under the brand name Wegovy for weight loss and Ozempic for type 2 diabetes. In the landmark STEP clinical trials, participants taking semaglutide lost an average of 15–17% of their body weight over 68 weeks when combined with lifestyle modifications.

Body Good Studio offers compounded semaglutide for adults pursuing medical weight loss — clinician-prescribed, shipped discreetly, and available with transparent pricing and insurance-friendly options.

Tirzepatide

Tirzepatide (Mounjaro for diabetes, Zepbound for weight loss) is a dual agonist: it activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. In the SURMOUNT-1 trial, participants lost up to 22.5% of their body weight on the highest dose — the most robust results seen in any non-surgical weight loss trial to date.

For adults who want to try tirzepatide before committing to a longer program, Body Good Studio offers a tirzepatide one-time trial that provides a single month of medication and clinician support.

Oral GLP-1 options

While most GLP-1 agonists are delivered via injection, oral formulations are now available. Rybelsus (oral semaglutide) is FDA-approved for diabetes and used off-label for weight management. For adults who prefer to start with an oral option, the oral GLP-1 (no commitment) program offers a trial without injections.

Who is a candidate for GLP-1 agonist therapy?

GLP-1 agonist medications are FDA-approved for adults with:

• A body mass index (BMI) of 30 or greater, or
• A BMI of 27 or greater with at least one weight-related condition (e.g., hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea)

Clinicians also consider:

• History of weight loss attempts
• Metabolic health markers
• Contraindications (e.g., personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2)
• Medication interactions
• Patient goals and preferences

This is why starting with a new patient consultation is essential. A licensed clinician reviews your full medical history, checks eligibility, and builds a personalized treatment plan — often within 24 hours.

What to expect when starting a GLP-1 agonist

Starting a GLP-1 agonist is a gradual process. Dosing begins low and increases every few weeks to minimize side effects and allow your body to adjust.

Typical titration schedule (semaglutide example)

• Weeks 1–4: 0.25 mg weekly
• Weeks 5–8: 0.5 mg weekly
• Weeks 9–12: 1.0 mg weekly
• Maintenance: 1.7 mg or 2.4 mg weekly, depending on response and tolerability

Common side effects

Most side effects are gastrointestinal and improve over time:

• Nausea (most common in the first 4–8 weeks)
• Constipation or diarrhea
• Bloating or reflux
• Reduced appetite (this is therapeutic, but can feel unusual at first)

If nausea becomes limiting, clinicians can prescribe anti-nausea medication like ondansetron to help you stay on protocol without interruption.

What weight loss looks like

Weight loss on a GLP-1 agonist is typically:

• Gradual: 1–2 pounds per week on average
• Front-loaded: more rapid in the first 3–6 months
• Sustained: clinical trials show maintenance for 1+ years with continued use
• Variable: individual response depends on starting weight, adherence, diet quality, activity level, and metabolic factors

This is not a quick fix. It's a tool that works best when paired with nutrition coaching, movement, sleep, and stress management.

Insurance coverage and cost

GLP-1 agonists can be expensive without coverage — often $900–$1,300 per month for brand-name options. However, many insurance plans now cover these medications for weight loss, especially when prescribed by a licensed clinician with proper documentation.

Body Good Studio is insurance-friendly and offers a GLP-1 insurance eligibility review, where a clinician evaluates your BMI, coverage pathway, and prior authorization requirements. You'll know exactly what your plan covers before starting treatment.

For adults without insurance coverage or seeking more affordable access, compounded semaglutide and tirzepatide are available through our programs at a fraction of the brand-name cost.

GLP-1 agonists vs. other weight loss medications

GLP-1 agonists are highly effective, but they're not the only option. Some adults cannot tolerate GLP-1s due to nausea, contraindications, or personal preference. In those cases, non-GLP-1 medications like bupropion / naltrexone may be appropriate. This combination works through different pathways — reducing cravings and modulating reward circuits in the brain.

A clinician can help you understand which medication class aligns with your health profile and goals.

How to start: telehealth makes it simple

Body Good Studio is a physician-led telehealth platform founded by Dr. Linda Moleon, MD. The process is designed to be accessible, discreet, and fast:

1. Take the free 60-second quiz at joinbodygood.com to check eligibility
2. Complete a brief health intake
3. Meet with a licensed clinician via telehealth (most patients get a treatment plan in under 24 hours)
4. Receive your prescription and medication shipped discreetly to your door
5. Get ongoing support, refills, and dosage adjustments as needed

No office visits. No waiting rooms. No judgment.

You can also use our free insurance probability checker to estimate your likelihood of coverage before your consultation.

Frequently Asked Questions

Ready to start your weight loss journey?

Body Good Studio's clinician-prescribed programs make medical weight loss with a GLP-1 agonist accessible, affordable, and personalized. Whether you're curious about semaglutide, tirzepatide, or alternative medications, our licensed clinicians will meet you where you are — with transparent pricing, insurance-friendly pathways, and bilingual support in English and Spanish.

Take our free 60-second quiz to see if you qualify — most members get a treatment plan in under 24 hours. No judgment. No waiting rooms. Just real clinical care, delivered to your door.

For more guidance on GLP-1 medications, check out our library of evidence-based articles at joinbodygood.com/blog.